The World CDx: Market Access for Precision Medicine 2017 is dedicated to regulatory, reimbursement and commercialization challenges facing precision medicine and diagnostic products.
The World CDx: Market Access for Precision Medicine 2017 covers topics such as:
- Dissecting the impact of regulatory changes on market access and commercialization
- Defining the value of precision medicines in healthcare
- Advancing pharma inter & intra co-alignment to achieve greater commercial success
- Regulatory & market access considerations for complex NGS diagnostics
- Tackling the role of IVDs in successful precision medicine market access
- Evolving pharma & diagnostic alignment to drive commercial success of precision medicines
- Advancing the Pharma-Diagnostic-Lab axis to improve commercial and patient access
- How RWE & health data can add value across the precision medicine market access strategy
- The impact of drug pricing on market access strategy
- How to bring precision medicines to those in need worldwide
The World CDx: Market Access for Precision Medicine 2017 brings together senior attendees from:
- Biotech
- Big Pharma
- FDA
- Complementary and CDx Developers
- Clinical Laboratories
- Payers
